Funding for this research was provided by:
Bahir Dar University (RCS/253/09)
Received: 8 September 2020
Accepted: 6 December 2020
First Online: 4 January 2021
Ethics approval and consent to participate
: The study was performed following ethical and applicable local regulatory requirements. It was reviewed and approved by the Ethical Review Committee of College of Medicine and Health Sciences at Bahir Dar University in Ethiopia (protocol number: 088/18-04), and permission to conduct the study was obtained from both regional and district administrations. This trial has been registered with the clinical ExternalRef removed registry database (NCT03612362).Written informed consent (or thumbprint witnessed by someone independent of the study for those unable to read and write) was obtained from each household head before randomization following distribution of written information sheets in <i>Amharic</i> (both national and study area language) to all eligible households. All ICSs were manufactured and installed by the same licensed company, and the management of intervention as well as the design, analysis, and reporting of the results was entirely independent of the manufacturer of the ICS.The Dylos HAP monitoring device is a CLASS-1 laser product that complies with title 21 of the Code of Federal Regulations (CFR), sections 1040.10 and 1040.11. In general, the study was performed following good ethical as well as applicable local and international legal requirements and standards for research.
: Not applicable
: The authors declare that they do not have competing interests.